Breaking News Instant updates and real-time market news.

2020-11-19 04:55:00 AAT American Assets Trust $28.18 / -0.965 (-3.31%) , ADC Agree Realty $64.43 / -2.265 (-3.40%) … 04:55 11/19/20 11/19 04:55 11/19/20 04:55	Mizuho to hold virtual company meetings at conference Mizuho Virtual Company Meetings at REITWorld on November 17-19. AAT American Assets Trust $28.18 / -0.965 (-3.31%) ADC Agree Realty $64.43 / -2.265 (-3.40%) AIV Aimco $31.34 / -0.95 (-2.94%) AMH American Homes 4 Rent $28.51 / -0.95 (-3.22%) ARE Alexandria Real Estate $162.55 / -2.625 (-1.59%) BDN Brandywine Realty $10.85 / -0.41 (-3.64%) BRX Brixmor $16.22 / -0.26 (-1.58%) BXP Boston Properties $96.15 / -2.34 (-2.38%) COR CoreSite Realty $127.20 / -0.81 (-0.63%) CPT Camden Property $97.94 / -3.9 (-3.83%) DEI Douglas Emmett $31.44 / -1.23 (-3.76%) DLR Digital Realty $142.40 / -0.05 (-0.04%) DOC Physicians Realty Trust $17.96 / -0.38 (-2.07%) OHI Omega Healthcare $33.75 / -1.35 (-3.85%) ESS Essex Property Trust $254.22 / -5.94 (-2.28%) FE FirstEnergy $28.54 / -0.2 (-0.70%) FR First Industrial Realty $41.87 / -1.16 (-2.70%) HIW Highwoods Properties $36.62 / -1.24 (-3.28%) HR Healthcare Realty Trust $30.71 / -1.05 (-3.31%) IDA Idacorp $90.51 / -2.89 (-3.09%) KIM Kimco Realty $14.54 / -0.53 (-3.52%) MAA MAA $126.06 / -4.85 (-3.70%) O Realty Income $61.15 / -1.68 (-2.67%) OFC Corporate Office Properties $26.51 / -0.34 (-1.27%) STOR Store Capital $31.52 / -0.72 (-2.23%) SITC Site Centers $9.79 / +0.12 (+1.24%) SAFE Safehold $66.92 / -1.62 (-2.36%) QTS QTS Realty Trust $62.60 / -0.41 (-0.65%)	19 Nov 19 Nov 07 Dec 03 Feb 10 Feb 20 Nov 07 Jan 27 Feb 18 Mar 31 Mar 05 May 29 May 02 Jun 07 Jul 18 Aug 11 Nov
AAT ADC AIV AMH ARE BDN BRX BXP COR CPT DEI DLR DOC OHI ESS FE FR HIW HR IDA KIM MAA O OFC STOR SITC SAFE QTS AAT American Assets Trust $28.18 / -0.965 (-3.31%) 05/21/20 Wells Fargo American Assets Trust price target lowered to $30 from $51 at Wells Fargo 05/18/20 Morgan Stanley Morgan Stanley downgrades American Assets Trust to Equal Weight, halves target 05/18/20 Morgan Stanley American Assets downgraded to Equal Weight from Overweight at Morgan Stanley ADC Agree Realty $64.43 / -2.265 (-3.40%) 10/12/20 BTIG Agree Realty initiated with a Buy at BTIG 09/29/20 Mizuho Agree Realty initiated with a Buy at Mizuho 07/02/20 Citi Agree Realty price target raised to $76 from $70 at Citi 06/10/20 Wells Fargo Agree Realty price target raised to $75 from $67 at Wells Fargo AIV Aimco $31.34 / -0.95 (-2.94%) 11/10/20 Mizuho Aimco price target lowered to $30 from $37 at Mizuho 09/18/20 Fly Intel: Top five analyst downgrades 09/18/20 Citi Aimco downgraded to Sell from Neutral at Citi 09/14/20 BofA Aimco upgraded to Neutral at BofA after split announcement AMH American Homes 4 Rent $28.51 / -0.95 (-3.22%) 10/01/20 Berenberg American Homes 4 Rent initiated with a Buy at Berenberg 09/24/20 Zelman American Homes 4 Rent upgraded to Buy from Hold at Zelman 06/23/20 Raymond James American Homes 4 Rent price target raised to $34 from $28 at Raymond James 06/18/20 Janney Montgomery Scott Janney starts American Homes 4 Rent at Neutral, sees better value elsewhere ARE Alexandria Real Estate $162.55 / -2.625 (-1.59%) 10/16/20 UBS Alexandria Real Estate initiated with a Neutral at UBS 10/02/20 Berenberg Alexandria Real Estate initiated with a Buy at Berenberg 09/02/20 RBC Capital Alexandria Real Estate price target raised to $184 from $175 at RBC Capital 07/20/20 Mizuho Alexandria Real Estate price target lowered to $185 from $190 at Mizuho BDN Brandywine Realty $10.85 / -0.41 (-3.64%) 10/12/20 Argus Brandywine Realty downgraded to Hold from Buy at Argus 10/12/20 Argus Brandywine Realty downgraded to Hold from Buy at Argus 07/20/20 Mizuho Brandywine Realty price target lowered to $11 from $16 at Mizuho 04/23/20 DA Davidson Brandywine Realty price target lowered to $10.50 from $17 at DA Davidson BRX Brixmor $16.22 / -0.26 (-1.58%) 07/08/20 Compass Point Brixmor downgraded to Neutral with $13 target at Compass Point 07/08/20 Compass Point Kimco Realty upgraded to Neutral with $13 target at Compass Point 07/08/20 Compass Point Brixmor downgraded to Neutral from Buy at Compass Point 07/02/20 Citi Brixmor price target raised to $13 from $9 at Citi BXP Boston Properties $96.15 / -2.34 (-2.38%) 11/16/20 Argus Boston Properties price target raised to $100 from $90 at Argus 10/19/20 Evercore ISI Boston Properties downgraded to In Line from Outperform at Evercore ISI 10/16/20 UBS Boston Properties initiated with a Neutral at UBS 08/14/20 Truist Boston Properties price target lowered to $108 from $121 at Truist COR CoreSite Realty $127.20 / -0.81 (-0.63%) 08/17/20 RBC Capital CoreSite Realty price target raised to $133 from $126 at RBC Capital 08/06/20 Raymond James CoreSite Realty upgraded to Outperform from Market Perform at Raymond James 08/04/20 Credit Suisse CoreSite Realty price target raised to $141 from $124 at Credit Suisse 07/15/20 Barclays CoreSite Realty initiated with an Underweight at Barclays CPT Camden Property $97.94 / -3.9 (-3.83%) 11/10/20 Mizuho Camden Property downgraded to Neutral from Buy at Mizuho 10/20/20 Wells Fargo Camden Property initiated with an Overweight at Wells Fargo 06/19/20 Stifel Camden Property added to Select List at Stifel 06/16/20 Truist Camden Property price target raised to $102 from $95 at SunTrust DEI Douglas Emmett $31.44 / -1.23 (-3.76%) 10/19/20 Mizuho Douglas Emmett price target lowered to $25 from $31 at Mizuho 10/14/20 Baird Douglas Emmett price target lowered to $33 from $35 at Baird 08/12/20 Jefferies Douglas Emmett downgraded to Hold at Jefferies on regulatory, macro challenges 08/12/20 Jefferies Douglas Emmett downgraded to Hold from Buy at Jefferies DLR Digital Realty $142.40 / -0.05 (-0.04%) 11/13/20 Fly Intel: Top five analyst upgrades 11/13/20 Citi Digital Realty upgraded to Buy from Neutral at Citi 11/02/20 Deutsche Bank Digital Realty pullback a buying opportunity, says Deutsche Bank 09/16/20 BMO Capital Digital Realty upgraded to Outperform from Market Perform at BMO Capital DOC Physicians Realty Trust $17.96 / -0.38 (-2.07%) 11/11/20 RBC Capital Physicians Realty Trust cut to Sector Perform from Outperform at RBC Capital 11/11/20 RBC Capital Physicians Realty downgraded to Sector Perform from Outperform at RBC Capital 09/30/20 Fly Intel: Top five analyst initiationsNewPage 09/30/20 Baird Physicians Realty Trust assumed with an Outperform at Baird OHI Omega Healthcare $33.75 / -1.35 (-3.85%) 10/02/20 Mizuho Omega Healthcare price target raised to $34 from $30 at Mizuho 10/02/20 Mizuho Omega Healthcare price target raised to $34 from $30 at Mizuho 09/14/20 Truist Omega Healthcare price target raised to $34 from $32 at Truist 09/01/20 Stifel Omega Healthcare resumed with a Buy at Stifel ESS Essex Property Trust $254.22 / -5.94 (-2.28%) 11/12/20 BTIG Essex Property Trust upgraded to Buy from Neutral at BTIG 11/12/20 BTIG Essex Property Trust upgraded to Buy from Neutral at BTIG 11/10/20 Mizuho Essex Property Trust upgraded to Buy from Neutral at Mizuho 10/20/20 Wells Fargo Essex Property Trust initiated with an Equal Weight at Wells Fargo FE FirstEnergy $28.54 / -0.2 (-0.70%) 11/18/20 Barclays FirstEnergy price target raised to $33 from $32 at Barclays 09/17/20 Mizuho FirstEnergy whistleblower suit reveals SEC investigation, says Mizuho 09/03/20 Fly Intel: Top five analyst upgrades 09/03/20 RBC Capital FirstEnergy upgraded to Outperform from Sector Perform at RBC Capital FR First Industrial Realty $41.87 / -1.16 (-2.70%) 11/13/20 Mizuho First Industrial Realty price target raised to $48 from $46 at Mizuho 09/29/20 Goldman Sachs First Industrial Realty resumed with a Sell at Goldman Sachs 08/04/20 Mizuho First Industrial Realty price target raised to $47 from $45 at Mizuho 07/24/20 Baird First Industrial Realty upgraded to Outperform from Neutral at Baird HIW Highwoods Properties $36.62 / -1.24 (-3.28%) 10/19/20 Mizuho Highwoods Properties price target lowered to $40 from $45 at Mizuho 06/25/20 Fly Intel: Top five analyst upgrades 06/24/20 Morgan Stanley Highwoods Properties upgraded to Overweight from Equal Weight at Morgan Stanley 04/28/20 Mizuho Highwoods Properties upgraded to Buy from Neutral at Mizuho HR Healthcare Realty Trust $30.71 / -1.05 (-3.31%) 11/04/20 BMO Capital Healthcare Realty Trust balance sheet still strong, says BMO Capital 09/18/20 Fly Intel: Top five analyst upgrades 09/18/20 Capital One Healthcare Realty Trust upgraded to Overweight from Equalweight at Capital One 09/01/20 Stifel Healthcare Realty Trust resumed with a Buy at Stifel IDA Idacorp $90.51 / -2.89 (-3.09%) 05/04/20 Sidoti Idacorp upgraded to Buy on valuation at Sidoti 05/04/20 Sidoti Idacorp upgraded to Buy from Neutral at Sidoti 03/18/20 BofA Idacorp upgraded to Buy from Neutral at BofA KIM Kimco Realty $14.54 / -0.53 (-3.52%) 11/03/20 Fly Intel: Top five analyst upgrades 11/03/20 Truist Kimco Realty upgraded to Buy from Hold at Truist 10/19/20 Evercore ISI Kimco Realty upgraded to In Line from Underperform at Evercore ISI 09/14/20 Morgan Stanley Kimco Realty upgraded to Overweight on free cash flow at Morgan Stanley MAA MAA $126.06 / -4.85 (-3.70%) 11/16/20 Truist MAA price target raised to $130 from $122 at Truist 11/10/20 Mizuho MAA price target raised to $128 from $115 at Mizuho 10/13/20 Jefferies Jefferies shakes up REIT ratings based on 'great migration of 2020' 10/13/20 Jefferies MAA upgraded to Buy from Hold at Jefferies O Realty Income $61.15 / -1.68 (-2.67%) 10/16/20 UBS Realty Income initiated with a Buy at UBS 10/12/20 Morgan Stanley Broadstone Net Lease initiated with an Overweight at Morgan Stanley 10/09/20 Scotiabank Scotiabank upgrades 'inexpensive' Realty Income to Outperform 10/09/20 Scotiabank Realty Income upgraded to Outperform from Sector Perform at Scotiabank OFC Corporate Office Properties $26.51 / -0.34 (-1.27%) 10/27/20 Wells Fargo Raytheon office reduction negative for office REITs, says Wells Fargo 10/27/20 Raymond James Corporate Office upgraded at Raymond James, pullback creates good entry point 10/27/20 Raymond James Corporate Office Properties upgraded to Outperform from Market Perform at Raymond James 08/25/20 JPMorgan Corporate Office Properties price target raised to $31 from $29 at JPMorgan STOR Store Capital $31.52 / -0.72 (-2.23%) 09/29/20 Mizuho Store Capital price target raised to $29 from $24 at Mizuho 09/18/20 Truist Store Capital price target raised to $27 from $24 at Truist 08/03/20 Fly Intel: Top five analyst initiations 08/03/20 Evercore ISI Store Capital initiated with an Outperform at Evercore ISI SITC Site Centers $9.79 / +0.12 (+1.24%) 11/10/20 Compass Point Compass Point upgrades four retail REITs to Neutral after Pfizer 'game changer' 11/09/20 Compass Point Site Centers upgraded to Neutral from Sell at Compass Point 07/02/20 Citi Site Centers price target raised to $8 from $5 at Citi 06/11/20 Raymond James Site Centers downgraded to Market Perform from Outperform at Raymond James SAFE Safehold $66.92 / -1.62 (-2.36%) 11/12/20 Mizuho Safehold price target raised to $75 from $70 at Mizuho 10/23/20 Mizuho Safehold price target raised to $70 from $56 at Mizuho 07/27/20 Mizuho Safehold upgraded to Buy from Neutral at Mizuho 07/27/20 Mizuho Safehold upgraded to Buy from Neutral at Mizuho QTS QTS Realty Trust $62.60 / -0.41 (-0.65%) 10/27/20 BMO Capital QTS Realty Trust price target raised to $73 from $70 at BMO Capital 07/30/20 KeyBanc QTS Realty Trust price target raised to $75 from $70 at KeyBanc 07/29/20 JPMorgan QTS Realty Trust price target raised to $76 from $70 at JPMorgan 07/29/20 Raymond James QTS Realty Trust upgraded to Outperform from Market Perform at Raymond James

2020-11-19 04:55:00

AAT

American Assets Trust

$28.18 / -0.965 (-3.31%)

, ADC

Agree Realty

$64.43 / -2.265 (-3.40%)

… 04:55

11/19/20

11/19

04:55

11/19/20

04:55

Mizuho to hold virtual company meetings at conference

Mizuho Virtual Company Meetings at REITWorld on November 17-19.

AAT

American Assets Trust

$28.18 / -0.965 (-3.31%)

ADC

Agree Realty

$64.43 / -2.265 (-3.40%)

AIV

Aimco

$31.34 / -0.95 (-2.94%)

AMH

American Homes 4 Rent

$28.51 / -0.95 (-3.22%)

ARE

Alexandria Real Estate

$162.55 / -2.625 (-1.59%)

BDN

Brandywine Realty

$10.85 / -0.41 (-3.64%)

BRX

Brixmor

$16.22 / -0.26 (-1.58%)

BXP

Boston Properties

$96.15 / -2.34 (-2.38%)

COR

CoreSite Realty

$127.20 / -0.81 (-0.63%)

CPT

Camden Property

$97.94 / -3.9 (-3.83%)

DEI

Douglas Emmett

$31.44 / -1.23 (-3.76%)

DLR

Digital Realty

$142.40 / -0.05 (-0.04%)

DOC

Physicians Realty Trust

$17.96 / -0.38 (-2.07%)

OHI

Omega Healthcare

$33.75 / -1.35 (-3.85%)

ESS

Essex Property Trust

$254.22 / -5.94 (-2.28%)

FirstEnergy

$28.54 / -0.2 (-0.70%)

First Industrial Realty

$41.87 / -1.16 (-2.70%)

HIW

Highwoods Properties

$36.62 / -1.24 (-3.28%)

Healthcare Realty Trust

$30.71 / -1.05 (-3.31%)

IDA

Idacorp

$90.51 / -2.89 (-3.09%)

KIM

Kimco Realty

$14.54 / -0.53 (-3.52%)

MAA

$126.06 / -4.85 (-3.70%)

Realty Income

$61.15 / -1.68 (-2.67%)

OFC

Corporate Office Properties

$26.51 / -0.34 (-1.27%)

STOR

Store Capital

$31.52 / -0.72 (-2.23%)

SITC

Site Centers

$9.79 / +0.12 (+1.24%)

SAFE

Safehold

$66.92 / -1.62 (-2.36%)

QTS

QTS Realty Trust

$62.60 / -0.41 (-0.65%)

19
Nov
19
Nov
07
Dec
03
Feb
10
Feb

20
Nov
07
Jan
27
Feb
18
Mar
31
Mar
05
May
29
May
02
Jun
07
Jul
18
Aug
11
Nov

AAT
ADC
AIV
AMH
ARE
BDN
BRX
BXP
COR
CPT
DEI
DLR
DOC
OHI
ESS
FE
FR
HIW
HR
IDA
KIM
MAA
O
OFC
STOR
SITC
SAFE
QTS

AAT American Assets Trust

$28.18 / -0.965 (-3.31%)

05/21/20 Wells Fargo: American Assets Trust price target lowered to $30 from $51 at Wells Fargo

05/18/20 Morgan Stanley: Morgan Stanley downgrades American Assets Trust to Equal Weight, halves target

05/18/20 Morgan Stanley: American Assets downgraded to Equal Weight from Overweight at Morgan Stanley

ADC Agree Realty

$64.43 / -2.265 (-3.40%)

10/12/20 BTIG: Agree Realty initiated with a Buy at BTIG

09/29/20 Mizuho: Agree Realty initiated with a Buy at Mizuho

07/02/20 Citi: Agree Realty price target raised to $76 from $70 at Citi

06/10/20 Wells Fargo: Agree Realty price target raised to $75 from $67 at Wells Fargo

AIV Aimco

$31.34 / -0.95 (-2.94%)

11/10/20 Mizuho: Aimco price target lowered to $30 from $37 at Mizuho

09/18/20: Fly Intel: Top five analyst downgrades

09/18/20 Citi: Aimco downgraded to Sell from Neutral at Citi

09/14/20 BofA: Aimco upgraded to Neutral at BofA after split announcement

AMH American Homes 4 Rent

$28.51 / -0.95 (-3.22%)

10/01/20 Berenberg: American Homes 4 Rent initiated with a Buy at Berenberg

09/24/20 Zelman: American Homes 4 Rent upgraded to Buy from Hold at Zelman

06/23/20 Raymond James: American Homes 4 Rent price target raised to $34 from $28 at Raymond James

06/18/20 Janney Montgomery Scott: Janney starts American Homes 4 Rent at Neutral, sees better value elsewhere

ARE Alexandria Real Estate

$162.55 / -2.625 (-1.59%)

10/16/20 UBS: Alexandria Real Estate initiated with a Neutral at UBS

10/02/20 Berenberg: Alexandria Real Estate initiated with a Buy at Berenberg

09/02/20 RBC Capital: Alexandria Real Estate price target raised to $184 from $175 at RBC Capital

07/20/20 Mizuho: Alexandria Real Estate price target lowered to $185 from $190 at Mizuho

BDN Brandywine Realty

$10.85 / -0.41 (-3.64%)

10/12/20 Argus: Brandywine Realty downgraded to Hold from Buy at Argus

10/12/20 Argus: Brandywine Realty downgraded to Hold from Buy at Argus

07/20/20 Mizuho: Brandywine Realty price target lowered to $11 from $16 at Mizuho

04/23/20 DA Davidson: Brandywine Realty price target lowered to $10.50 from $17 at DA Davidson

BRX Brixmor

$16.22 / -0.26 (-1.58%)

07/08/20 Compass Point: Brixmor downgraded to Neutral with $13 target at Compass Point

07/08/20 Compass Point: Kimco Realty upgraded to Neutral with $13 target at Compass Point

07/08/20 Compass Point: Brixmor downgraded to Neutral from Buy at Compass Point

07/02/20 Citi: Brixmor price target raised to $13 from $9 at Citi

BXP Boston Properties

$96.15 / -2.34 (-2.38%)

11/16/20 Argus: Boston Properties price target raised to $100 from $90 at Argus

10/19/20 Evercore ISI: Boston Properties downgraded to In Line from Outperform at Evercore ISI

10/16/20 UBS: Boston Properties initiated with a Neutral at UBS

08/14/20 Truist: Boston Properties price target lowered to $108 from $121 at Truist

COR CoreSite Realty

$127.20 / -0.81 (-0.63%)

08/17/20 RBC Capital: CoreSite Realty price target raised to $133 from $126 at RBC Capital

08/06/20 Raymond James: CoreSite Realty upgraded to Outperform from Market Perform at Raymond James

08/04/20 Credit Suisse: CoreSite Realty price target raised to $141 from $124 at Credit Suisse

07/15/20 Barclays: CoreSite Realty initiated with an Underweight at Barclays

CPT Camden Property

$97.94 / -3.9 (-3.83%)

11/10/20 Mizuho: Camden Property downgraded to Neutral from Buy at Mizuho

10/20/20 Wells Fargo: Camden Property initiated with an Overweight at Wells Fargo

06/19/20 Stifel: Camden Property added to Select List at Stifel

06/16/20 Truist: Camden Property price target raised to $102 from $95 at SunTrust

DEI Douglas Emmett

$31.44 / -1.23 (-3.76%)

10/19/20 Mizuho: Douglas Emmett price target lowered to $25 from $31 at Mizuho

10/14/20 Baird: Douglas Emmett price target lowered to $33 from $35 at Baird

08/12/20 Jefferies: Douglas Emmett downgraded to Hold at Jefferies on regulatory, macro challenges

08/12/20 Jefferies: Douglas Emmett downgraded to Hold from Buy at Jefferies

DLR Digital Realty

$142.40 / -0.05 (-0.04%)

11/13/20: Fly Intel: Top five analyst upgrades

11/13/20 Citi: Digital Realty upgraded to Buy from Neutral at Citi

11/02/20 Deutsche Bank: Digital Realty pullback a buying opportunity, says Deutsche Bank

09/16/20 BMO Capital: Digital Realty upgraded to Outperform from Market Perform at BMO Capital

DOC Physicians Realty Trust

$17.96 / -0.38 (-2.07%)

11/11/20 RBC Capital: Physicians Realty Trust cut to Sector Perform from Outperform at RBC Capital

11/11/20 RBC Capital: Physicians Realty downgraded to Sector Perform from Outperform at RBC Capital

09/30/20: Fly Intel: Top five analyst initiationsNewPage

09/30/20 Baird: Physicians Realty Trust assumed with an Outperform at Baird

OHI Omega Healthcare

$33.75 / -1.35 (-3.85%)

10/02/20 Mizuho: Omega Healthcare price target raised to $34 from $30 at Mizuho

10/02/20 Mizuho: Omega Healthcare price target raised to $34 from $30 at Mizuho

09/14/20 Truist: Omega Healthcare price target raised to $34 from $32 at Truist

09/01/20 Stifel: Omega Healthcare resumed with a Buy at Stifel

ESS Essex Property Trust

$254.22 / -5.94 (-2.28%)

11/12/20 BTIG: Essex Property Trust upgraded to Buy from Neutral at BTIG

11/12/20 BTIG: Essex Property Trust upgraded to Buy from Neutral at BTIG

11/10/20 Mizuho: Essex Property Trust upgraded to Buy from Neutral at Mizuho

10/20/20 Wells Fargo: Essex Property Trust initiated with an Equal Weight at Wells Fargo

FE FirstEnergy

$28.54 / -0.2 (-0.70%)

11/18/20 Barclays: FirstEnergy price target raised to $33 from $32 at Barclays

09/17/20 Mizuho: FirstEnergy whistleblower suit reveals SEC investigation, says Mizuho

09/03/20: Fly Intel: Top five analyst upgrades

09/03/20 RBC Capital: FirstEnergy upgraded to Outperform from Sector Perform at RBC Capital

FR First Industrial Realty

$41.87 / -1.16 (-2.70%)

11/13/20 Mizuho: First Industrial Realty price target raised to $48 from $46 at Mizuho

09/29/20 Goldman Sachs: First Industrial Realty resumed with a Sell at Goldman Sachs

08/04/20 Mizuho: First Industrial Realty price target raised to $47 from $45 at Mizuho

07/24/20 Baird: First Industrial Realty upgraded to Outperform from Neutral at Baird

HIW Highwoods Properties

$36.62 / -1.24 (-3.28%)

10/19/20 Mizuho: Highwoods Properties price target lowered to $40 from $45 at Mizuho

06/25/20: Fly Intel: Top five analyst upgrades

06/24/20 Morgan Stanley: Highwoods Properties upgraded to Overweight from Equal Weight at Morgan Stanley

04/28/20 Mizuho: Highwoods Properties upgraded to Buy from Neutral at Mizuho

HR Healthcare Realty Trust

$30.71 / -1.05 (-3.31%)

11/04/20 BMO Capital: Healthcare Realty Trust balance sheet still strong, says BMO Capital

09/18/20: Fly Intel: Top five analyst upgrades

09/18/20 Capital One: Healthcare Realty Trust upgraded to Overweight from Equalweight at Capital One

09/01/20 Stifel: Healthcare Realty Trust resumed with a Buy at Stifel

IDA Idacorp

$90.51 / -2.89 (-3.09%)

05/04/20 Sidoti: Idacorp upgraded to Buy on valuation at Sidoti

05/04/20 Sidoti: Idacorp upgraded to Buy from Neutral at Sidoti

03/18/20 BofA: Idacorp upgraded to Buy from Neutral at BofA

KIM Kimco Realty

$14.54 / -0.53 (-3.52%)

11/03/20: Fly Intel: Top five analyst upgrades

11/03/20 Truist: Kimco Realty upgraded to Buy from Hold at Truist

10/19/20 Evercore ISI: Kimco Realty upgraded to In Line from Underperform at Evercore ISI

09/14/20 Morgan Stanley: Kimco Realty upgraded to Overweight on free cash flow at Morgan Stanley

MAA MAA

$126.06 / -4.85 (-3.70%)

11/16/20 Truist: MAA price target raised to $130 from $122 at Truist

11/10/20 Mizuho: MAA price target raised to $128 from $115 at Mizuho

10/13/20 Jefferies: Jefferies shakes up REIT ratings based on 'great migration of 2020'

10/13/20 Jefferies: MAA upgraded to Buy from Hold at Jefferies

O Realty Income

$61.15 / -1.68 (-2.67%)

10/16/20 UBS: Realty Income initiated with a Buy at UBS

10/12/20 Morgan Stanley: Broadstone Net Lease initiated with an Overweight at Morgan Stanley

10/09/20 Scotiabank: Scotiabank upgrades 'inexpensive' Realty Income to Outperform

10/09/20 Scotiabank: Realty Income upgraded to Outperform from Sector Perform at Scotiabank

OFC Corporate Office Properties

$26.51 / -0.34 (-1.27%)

10/27/20 Wells Fargo: Raytheon office reduction negative for office REITs, says Wells Fargo

10/27/20 Raymond James: Corporate Office upgraded at Raymond James, pullback creates good entry point

10/27/20 Raymond James: Corporate Office Properties upgraded to Outperform from Market Perform at Raymond James

08/25/20 JPMorgan: Corporate Office Properties price target raised to $31 from $29 at JPMorgan

STOR Store Capital

$31.52 / -0.72 (-2.23%)

09/29/20 Mizuho: Store Capital price target raised to $29 from $24 at Mizuho

09/18/20 Truist: Store Capital price target raised to $27 from $24 at Truist

08/03/20: Fly Intel: Top five analyst initiations

08/03/20 Evercore ISI: Store Capital initiated with an Outperform at Evercore ISI

SITC Site Centers

$9.79 / +0.12 (+1.24%)

11/10/20 Compass Point: Compass Point upgrades four retail REITs to Neutral after Pfizer 'game changer'

11/09/20 Compass Point: Site Centers upgraded to Neutral from Sell at Compass Point

07/02/20 Citi: Site Centers price target raised to $8 from $5 at Citi

06/11/20 Raymond James: Site Centers downgraded to Market Perform from Outperform at Raymond James

SAFE Safehold

$66.92 / -1.62 (-2.36%)

11/12/20 Mizuho: Safehold price target raised to $75 from $70 at Mizuho

10/23/20 Mizuho: Safehold price target raised to $70 from $56 at Mizuho

07/27/20 Mizuho: Safehold upgraded to Buy from Neutral at Mizuho

07/27/20 Mizuho: Safehold upgraded to Buy from Neutral at Mizuho

QTS QTS Realty Trust

$62.60 / -0.41 (-0.65%)

10/27/20 BMO Capital: QTS Realty Trust price target raised to $73 from $70 at BMO Capital

07/30/20 KeyBanc: QTS Realty Trust price target raised to $75 from $70 at KeyBanc

07/29/20 JPMorgan: QTS Realty Trust price target raised to $76 from $70 at JPMorgan

07/29/20 Raymond James: QTS Realty Trust upgraded to Outperform from Market Perform at Raymond James

TODAY'S FREE FLY STORIES

Recommendations	Clearside enrollment speed 'encouraging,' says Roth Capital » 11:04 03/02/21 03/02 11:04 03/02/21 11:04 CLSD Clearside Biomedical $3.47 / +0.02 (+0.58%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CLSD Clearside Biomedical $3.47 / +0.02 (+0.58%) 07:54 Today Clearside completes dosing in first cohort of Phase 1/2a trial of CLS-AX 02/16/21 Clearside Biomedical announces presentation on CLS-AX 02/08/21 Clearside featured in multiple data presentations at Macula Society meeting 01/12/21 Clearside Biomedical enrolls first patients in Phase 1/2a trial of CLS-AX CLSD Clearside Biomedical $3.47 / +0.02 (+0.58%) 12/03/20 Roth Capital Clearside platform validated by Janssen deal, says Roth Capital 08/06/20 Roth Capital Investors should buy 'highly undervalued' Clearside, says Roth Capital 06/19/20 Roth Capital Clearside Biomedical abstracts highlight strength, says Roth Capital 05/13/20 Fly Intel: Top five analyst initiations CLSD Clearside Biomedical $3.47 / +0.02 (+0.58%) 11/10/20 Clearside Biomedical reports Q EPS , consensus 03/15/21 33rd Annual Roth Virtual Conference 03/10/21 Clearside Biomedical - CLSD
Upgrade	Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback » 11:04 03/02/21 03/02 11:04 03/02/21 11:04 ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) , BAYRY Bayer $0.00 / + (+0.00%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly ATRA BAYRY ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 02/08/21 Atara Biotherapeutics to present tabelecleucel data at ASTCT meeting 01/04/21 Atara Biotherapeutics provides update on BLA submission for tab-cel 12/07/20 Atara presents evaluation of CAR T Cell Therapy ATA3219 at ASH 12/07/20 Bayer, Atara Biotherapeutics enter collaboration on CAR T-cell therapies BAYRY Bayer $0.00 / + (+0.00%) 02/24/21 Bayer to divest Environmental Science Professional business 02/17/21 Selecta, AskBio initiate first-in-human dose escalation study of ImmTOR 02/05/21 CureVac enters pact with UK Government to develop SARS-CoV-2 variant vaccine 02/03/21 Bayer announes $2B agreement to resolve future Roundup cases ATRA BAYRY ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 11:00 Today Citi Atara Biotherapeutics upgraded to Buy from Neutral at Citi 01/04/21 Roth Capital Roth keeps Buy rating on Atara Biotherapeutics after filing delay 01/04/21 Roth Capital Roth keeps Buy rating on Atara as initiation of BLA gets 'slightly' delayed 12/09/20 Citi Atara Biotherapeutics downgraded to Neutral from Buy at Citi BAYRY Bayer $0.00 / + (+0.00%) 03/01/21 Morgan Stanley Bayer price target lowered to EUR 66 from EUR 68 at Morgan Stanley 02/26/21 Credit Suisse Bayer price target raised to EUR 56 from EUR 55 at Credit Suisse 02/10/21 Barclays Bayer price target raised to EUR 55 from EUR 50 at Barclays 02/04/21 Citi opens positive 'Catalyst Watch' on Bayer ATRA BAYRY ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 03/01/21 Atara Biotherapeutics reports Q4 EPS (95c), consensus (74c) 11/12/20 Atara Biotherapeutics to present preclinical data on ATA3271 at SITC 2020 11/09/20 Atara Biotherapeutics reports Q3 EPS (92c), consensus ($1.09) BAYRY Bayer $0.00 / + (+0.00%) 02/25/21 Bayer sees 2021 core EPS approx. EUR5.60-EUR5.80 02/25/21 Bayer reports Q4 core EPS EUR1.32 vs. EUR1.44 last year 11/03/20 Bayer confirms FY20 targets, sees core EPS EUR6.70-EUR6.90 11/03/20 Bayer reports Q3 core EPS down 30.2% to EUR0.81 09 Dec 27 May BAYRY BAYRY Bayer $0.00 / + (+0.00%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 10/27/20 EPA clears use of Bayer's XtendiMax for five years, Reuters reports 10/11/20 Bayer, BASF fighting to keep weedkiller on U.S. farms, WSJ reports 09/15/20 Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says ATRA BAYRY ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 12/07/20 Fly Intel: Pre-market Movers BAYRY Bayer $0.00 / + (+0.00%) 01/07/21 Fly Intel: Pre-market Movers 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/29/20 Fly Intel: Wall Street's top stories for Tuesday
Hot Stocks	Capri Holdings appoints Alejandro Martinez-Galindo as CIO » 11:04 03/02/21 03/02 11:04 03/02/21 11:04 CPRI Capri Holdings $47.97 / -0.26 (-0.54%) , WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) Capri Holdings (CPRI)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 02/03/21 Capri Holdings sees lower Q4 revenue than previously expected 01/07/21 Capri Holdings to replace Enphase Energy in the S&P 400 at open on January 7 01/06/21 Celsius Holdings confirms addition to S&P SmallCap 600 Index, effective Jan. 7 12/30/20 Capri Holdings to replace Enphase Energy in the S&P 400 at open on January 7 WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 02/24/21 Walgreens says Pixel by Labcorp COVID-19 PCR test to be available OTC nationwide 02/24/21 CRL makes first at-home COVID-19 saliva test available through Walgreens 02/23/21 Walgreens launches rollout of same-day delivery with Instacart 02/19/21 Walgreens provides over 3M COVID-19 vaccinations CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 02/04/21 Capri Holdings price target raised to $52 from $50 at Barclays 01/29/21 Baird Capri upgraded to Outperform on multi-year recovery at Baird 01/29/21 Baird Capri Holdings upgraded to Outperform from Neutral at Baird 01/27/21 Citi Capri Holdings price target raised to $53 from $32 at Citi WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 01/27/21 Deutsche Bank Walgreens Boots Alliance price target raised to $49 from $44 at Deutsche Bank 01/15/21 Baird Walgreens Boots Alliance price target raised to $64 from $55 at Baird 01/11/21 Fly Intel: Top five analyst upgrades 01/11/21 Baird Baird upgrades Walgreens Boots Alliance following Q1 results CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 02/03/21 Capri Holdings reports Q3 adjusted EPS $1.65, consensus $1.01 11/05/20 Capri Holdings sees Q3 sales down double digits, consensus $1.27B 11/05/20 Capri Holdings sees FY sales down approximately 30%, consensus $3.79B 11/05/20 Capri Holdings not providing earnings guidance for FY21 WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 01/07/21 Walgreens Boots Alliance backs FY21 adjusted EPS view up low single digits 01/07/21 Walgreens Boots Alliance reports Q1 adjusted EPS $1.22, consensus $1.03 01/06/21 Notable companies reporting before tomorrow's open 01/06/21 Notable companies reporting before tomorrow's open CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 10/26/20 Hedgeye adds Capri Holdings to best ideas list, Bloomberg says WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 02/14/21 Walmart COVID vaccine rollout heading to small towns, WSJ reports 01/26/21 Walgreens Boots Alliance set to name Starbucks COO Roz Brewer as CEO, WSJ says 01/26/21 Walgreens to name Starbucks executive Roz Brewer as CEO, WSJ says 12/20/20 CDC panel says frontline workers, people over 74 should be next, NYTimes reports CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 12/31/20 Fly Intel: Pre-market Movers 12/30/20 Fly Intel: After-Hours Movers 11/20/20 Nikola initiation at Loop among today's top calls on Wall Street 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 01/27/21 Fly Intel: Wall Street's top stories for Wednesday 01/27/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: After-Hours Movers 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 03/31/21 Walgreens Boots Alliance - WBA CPRI WBA CPRI Capri Holdings $47.97 / -0.26 (-0.54%) 02/10/21 Capri Holdings put volume heavy and directionally bearish 02/08/21 Capri Holdings put volume heavy and directionally bearish 01/29/21 Capri Holdings put volume heavy and directionally bearish 01/27/21 Capri Holdings put volume heavy and directionally bearish WBA Walgreens Boots Alliance $47.45 / -0.42 (-0.88%) 02/09/21 Walgreen Boots call volume above normal and directionally bullish 01/29/21 Walgreen Boots call volume above normal and directionally bullish 01/11/21 Early notable gainers among liquid option names on January 11th 12/31/20 Walgreen Boots call volume above normal and directionally bullish
Hot Stocks	Activision Blizzard appoints Frances Townsend as EVP, corporate affairs » 11:02 03/02/21 03/02 11:02 03/02/21 11:02 ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) Activision Blizzard… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/23/21 Activision says 'Tony Hawk' remake coming to PS5, Xbox Series, Switch 02/19/21 Blizzard unveils 'Diablo II: Resurrected' for PC, consoles 02/19/21 Activision Blizzard says 'Burning Crusade' expansion coming to 'WoW Classic' 02/19/21 Blizzard unveils 'Blizzard Arcade Collection' for PC, consoles ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/23/21 Benchmark Activision Blizzard price target raised to $118 from $109 at Benchmark 02/19/21 Citi Activision Blizzard price target raised to $110 from $83 at Citi 02/18/21 Argus Activision Blizzard price target raised to $122 from $102 at Argus 02/18/21 Deutsche Bank Activision Blizzard price target raised to $115 from $100 at Deutsche Bank ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/04/21 Activision Blizzard sees FY21 EPS $3.34, consensus $3.51 02/04/21 Activision Blizzard sees Q1 EPS 84c, consensus 65c 02/04/21 Activision Blizzard reports Q4 EPS 76c, consensus $1.18 02/04/21 Notable companies reporting after market close ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/18/21 Saudi Arabia's PIF buys $3.3B worth of Activision, EA, Take-Two, Bloomberg says 02/08/21 ESA proceeds with plans for digital E3 this summer, VGC reports 01/27/21 Activision Blizzard rejects AFL-CIO proposals to diversify hiring, Vice reports 01/22/21 Activision shifts Vicarious Visions studio into Blizzard, Gamesindustry.biz says ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/23/21 Game On: An exclusive talk with Skeleton Crew's Olsson and Murakami 02/16/21 Game On: NPD reports 42% growth in U.S. game spending in January 02/09/21 Game On: Big three publishers report earnings as EA to acquire Glu 02/05/21 Peloton downgrade among today's top calls on Wall Street 03/10/21 2021 Technology, Internet & Services Virtual Conference ATVI Activision Blizzard $97.08 / -1.66 (-1.68%) 02/05/21 Early notable gainers among liquid option names on February 5th 01/19/21 Activision Blizzard call volume above normal and directionally bullish 11/30/20 Activision Blizzard call volume above normal and directionally bullish 11/12/20 Early notable gainers among liquid option names on November 12th
Syndicate	Orion Acquisition opens for trade at $10.05, IPO priced at $10 » 11:00 03/02/21 03/02 11:00 03/02/21 11:00 OPHA Orion Acquisition $0.00 / + (+0.00%) Orion Acquisition, a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Upgrade	Atara Biotherapeutics upgraded to Buy from Neutral at Citi » 11:00 03/02/21 03/02 11:00 03/02/21 11:00 ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) Citi analyst Yigal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) 02/08/21 Atara Biotherapeutics to present tabelecleucel data at ASTCT meeting 01/04/21 Atara Biotherapeutics provides update on BLA submission for tab-cel 12/07/20 Atara presents evaluation of CAR T Cell Therapy ATA3219 at ASH 12/07/20 Bayer, Atara Biotherapeutics enter collaboration on CAR T-cell therapies ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) 01/04/21 Roth Capital Roth keeps Buy rating on Atara Biotherapeutics after filing delay 01/04/21 Roth Capital Roth keeps Buy rating on Atara as initiation of BLA gets 'slightly' delayed 12/09/20 Citi Atara Biotherapeutics downgraded to Neutral from Buy at Citi 12/08/20 H.C. Wainwright Atara Biotherapeutics price target raised to $31 from $28 at H.C. Wainwright ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) 03/01/21 Atara Biotherapeutics reports Q4 EPS (95c), consensus (74c) 11/12/20 Atara Biotherapeutics to present preclinical data on ATA3271 at SITC 2020 11/09/20 Atara Biotherapeutics reports Q3 EPS (92c), consensus ($1.09) 09 Dec 27 May ATRA Atara Biotherapeutics $16.54 / -0.53 (-3.10%) 12/07/20 Fly Intel: Pre-market Movers
Recommendations	CAE price target raised to C$40 from C$34 at TD Securities » 10:59 03/02/21 03/02 10:59 03/02/21 10:59 CAE CAE $29.48 / -0.47 (-1.57%) TD Securities analyst Tim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CAE CAE $29.48 / -0.47 (-1.57%) 03/01/21 CAE to acquire L3Harris Technologies military training business for $1.05B 03/01/21 L3Harris Technologies to sell Military Training, Combat Propulsion for $1.45B 02/12/21 CAE sees 2021 CapEx $100M 02/02/21 CAE signs contract with Pyure to assemble anti-COVID-19 air sanitizers CAE CAE $29.48 / -0.47 (-1.57%) 02/16/21 TD Securities CAE price target raised to C$34 from C$33 at TD Securities 02/16/21 Scotiabank CAE price target raised to C$39 from C$38 at Scotiabank 02/16/21 Canaccord CAE price target raised to C$34 from C$32 at Canaccord 01/04/21 CIBC CAE price target raised to C$36 from C$33 at CIBC CAE CAE $29.48 / -0.47 (-1.57%) 02/12/21 CAE reports Q3 EPS ex-items C$0.22 vs. C$0.37 a year ago 11/10/20 CAE reports Q2 EPS C$0.13 vs. C$0.28 a year ago CAE CAE $29.48 / -0.47 (-1.57%) 02/28/21 CAE near deal to acquire L3Harris military-training unit, WSJ reports CAE CAE $29.48 / -0.47 (-1.57%) 11/16/20 Fly Intel: After-Hours Movers 05/19/21 CAE - CAE
Syndicate	NightDragon Acquisition opens at $10.25, IPO priced at $10 per unit » 10:56 03/02/21 03/02 10:56 03/02/21 10:56 NDAC NightDragon Acquisition $0.00 / + (+0.00%) NightDragon Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	Target 'off to a strong start' in February, with comps up 20% » 10:55 03/02/21 03/02 10:55 03/02/21 10:55 TGT Target $175.50 / -10.62 (-5.71%) Comments taken from Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TGT Target $175.50 / -10.62 (-5.71%) 09:57 Today Target says testing new sortation center to expedite online orders 09:16 Today Target says 'our business model is working as intended' 08:52 Today Target not providing FY21 guidance 'in the face of continued uncertainty' 06:38 Today Target reports Q4 digital comparable sales grew 118% TGT Target $175.50 / -10.62 (-5.71%) 02/09/21 Jefferies Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Stifel Target upgraded to Buy from Hold at Stifel 01/14/21 DA Davidson Target price target raised to $229 from $208 at DA Davidson TGT Target $175.50 / -10.62 (-5.71%) 06:34 Today Target reports Q4 adjusted EPS $2.67, consensus $2.54 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 11/18/20 Target reports Q3 total revenue $22.63B, consensus $20.93B TGT Target $175.50 / -10.62 (-5.71%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/06/20 Chick-fil-A sues Tyson, others for poultry price-fixing, Bloomberg says 11/14/20 Targe booming during pandemic, stock still undervalued, Barron's says 10/24/20 Sprouts Farmers ready for rebound, Barron's says TGT Target $175.50 / -10.62 (-5.71%) 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 09:00 Today Target - TGT 09:00 Today Target Corporation TGT Target $175.50 / -10.62 (-5.71%) 09:55 Today Early notable gainers among liquid option names on March 2nd 09:40 Today Unusually active option classes on open March 2nd 11/19/20 Early notable gainers among liquid option names on November 19th 11/17/20 Unusually active option classes on open November 17th
Options	Two Harbors put volume heavy and directionally bearish » 10:55 03/02/21 03/02 10:55 03/02/21 10:55 TWO Two Harbors $7.16 / -0.03 (-0.42%) Bearish flow noted in Two… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events TWO Two Harbors $7.16 / -0.03 (-0.42%) 12/18/20 Keefe Bruyette Two Harbors downgraded to Market Perform from Outperform at Keefe Bruyette 12/14/20 Jefferies Two Harbors initiated with a Hold at Jefferies 12/10/20 Barclays Two Harbors downgraded to Equal Weight from Overweight at Barclays 11/24/20 Raymond James Two Harbors downgraded to Market Perform from Outperform at Raymond James TWO Two Harbors $7.16 / -0.03 (-0.42%) 02/09/21 Two Harbors reports Q4 core EPS 30c, consensus 23c 11/04/20 Two Harbors reports Q3 EPS 28c, consensus 24c 05/19/21 Two Harbors Investment Corp

Conference/Events	Seelos Therapeutics participates in a conference call with Benchmark » 10:55 03/02/21 03/02 10:55 03/02/21 10:55 SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) Healthcare Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events Options SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) 02/18/21 Seelos Therapeutics amends agreement to repurchase royalties for SLS-002 01/29/21 Seelos Therapeutics receives patent covering SLS-005 in Australia 01/22/21 Seelos Therapeutics receives Notice of Allowance in Japan for SLS-005 01/15/21 Seelos Therapeutics says first patients dosed in study of SLS-002 SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) 09/09/20 Roth Capital Seelos Therapeutics shares 'substantially undervalued,' says Roth Capital 06/23/20 Roth Capital Seelos Therapeutics price target raised to $12 from $8 Roth Capital 26 Jan 12 Mar SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) 01/25/21 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 03/10/21 Seelos Therapeutics - SEEL SEEL Seelos Therapeutics $3.04 / -0.07 (-2.25%) 02/23/21 One new option listing and one option delisting on February 23rd
Syndicate	Anzu Special Acquisition Corp I opens at $10, IPO priced at $10 per unit » 10:51 03/02/21 03/02 10:51 03/02/21 10:51 ANZU Anzu Special Acquisition Corp I $0.00 / + (+0.00%) Anzu Special Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Syndicate	Northern Star Investment Corp. IV opens at $10.15, IPO priced at $10 » 10:49 03/02/21 03/02 10:49 03/02/21 10:49 NSTD Northern Star Investment Corp. IV $0.00 / + (+0.00%) Northern Star Investment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Syndicate	Northern Star Investment Corp. III opens a $10.15, IPO priced at $10 » 10:47 03/02/21 03/02 10:47 03/02/21 10:47 NSTC Northern Star Investment Corp. III $0.00 / + (+0.00%) Northern Star Investment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Syndicate	Live Oak Mobility Acquisition opens at $10.29, IPO priced at $10 » 10:45 03/02/21 03/02 10:45 03/02/21 10:45 LOKM Live Oak Mobility Acquisition $0.00 / + (+0.00%) Live Oak Mobility… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Options	Aurora Cannabis call volume above normal and directionally bullish » 10:45 03/02/21 03/02 10:45 03/02/21 10:45 ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/22/21 NJ Governor signs bill to legalize adult-use cannabis 02/11/21 Aurora Cannabis jumps 10% to $15.90 after reporting Q2 results 02/11/21 Aurora Cannabis CEO: Aurora had an excellent second quarter 02/11/21 Aurora Cannabis falls -20.3% ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/16/21 CIBC Aurora Cannabis price target raised to C$18.50 from C$17 at CIBC 02/16/21 GLJ Research Aurora Cannabis shares have 100% downside by end of 2022, says GLJ Research 02/12/21 Canaccord Aurora Cannabis price target raised to C$14 from C$11 at Canaccord 02/12/21 MKM Partners Aurora Cannabis downgraded to Sell from Neutral at MKM Partners ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/11/21 Aurora Cannabis reports Q2 revenue C$67.67M, vs. C$55.14M a year ago 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 22 Jan 11 Nov ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/10/21 Tilray jumps as Reddit crowd turns attention to pot, Bloomberg says 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/11/21 Tilray, other pot stocks slide as Reddit trade loses momentum 02/04/21 Rising High: An exclusive talk with health and wellness CBD company HempFusion ACB Aurora Cannabis $11.68 / +0.65 (+5.89%) 02/11/21 Aurora Cannabis options imply 26.2% move in share price post-earnings 02/10/21 Aurora Cannabis call volume above normal and directionally bullish 02/09/21 Aurora Cannabis call volume above normal and directionally bullish 02/08/21 Aurora Cannabis call volume above normal and directionally bullish
General news	4-Week Bill Announcement to be released at 11:00 10:45 03/02/21 03/02 10:45 03/02/21 10:45
General news	8-Week Bill Announcement to be released at 11:00 10:45 03/02/21 03/02 10:45 03/02/21 10:45
Conference/Events	Ideaya Biosciences management to meet virtually with Wedbush » 10:44 03/02/21 03/02 10:44 03/02/21 10:44 IDYA Ideaya Biosciences $19.60 / +0.01 (+0.05%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events IDYA Ideaya Biosciences $19.60 / +0.01 (+0.05%) 02/08/21 Ideaya Biosciences' IND for IDE397 in cancer cleared by FDA 01/19/21 Ideaya Biosciences, Spelman College partner in female African American education 01/11/21 Ideaya Biosciences submits IND application to FDA for intiaition of IDE397 trial 01/05/21 Ideaya Biosciences announces first patient dosed in study of IDE196, crizotinib IDYA Ideaya Biosciences $19.60 / +0.01 (+0.05%) 01/29/21 Baird Ideaya Biosciences assumed at Outperform at Baird 01/06/21 Northland Ideaya Biosciences named a top pick in small cap biotech at Northland 01/05/21 Roth Capital Ideaya combo trial opens up large opportunity, says Roth Capital 10/06/20 Wedbush Wedbush starts Ideaya Biosciences at Outperform with $21 price target IDYA Ideaya Biosciences $19.60 / +0.01 (+0.05%) 11/12/20 Ideaya Biosciences reports Q3 EPS (17c) vs. (54c) last year 18 Jun 03/16/21 31st Annual Healthcare Virtual Conference 03/08/21 Ideaya Biosciences 04/20/21 IDEAYA Biosciences, Inc.
Recommendations	Alliance Global raises OpGen price target to $7, sees 'eventful 2021' » 10:44 03/02/21 03/02 10:44 03/02/21 10:44 OPGN OpGen $2.12 / -0.05 (-2.30%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OPGN OpGen $2.12 / -0.05 (-2.30%) 03/01/21 OpGen wins Chinese NMPA approval for Curetis Unyvero System 02/16/21 Ares Genetics announces publication of study on prediction of AST results 01/05/21 OpGen's Curetis, Annar enter Unyvero distribution partnership 12/17/20 OpGen announces publication on Unyvero LRT BAL panel OPGN OpGen $2.12 / -0.05 (-2.30%) 11/13/20 Alliance Global Partners OpGen price target raised to $5.65 from $5.00 at Alliance Global Partners 06/09/20 Alliance Global Partners Alliance Global Partners sees OpGen preliminary data as positive 06/03/20 Alliance Global Partners OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global OPGN OpGen $2.12 / -0.05 (-2.30%) 01/13/21 OpGen reports preliminary 2020 revenue $5.2M, consensus $4.15M 01/13/21 OpGen reports preliminary Q4 revenue $1.3M, two est. $1.4M 10/15/20 OpGen reports preliminary Q3 revenue approx. $1M, one est. $1.6M

Recommendations	Columbus McKinnon price target raised to $67 from $56 at Barrington » 10:42 03/02/21 03/02 10:42 03/02/21 10:42 CMCO Columbus McKinnon $53.06 / +0.86 (+1.65%) Barrington analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CMCO Columbus McKinnon $53.06 / +0.86 (+1.65%) 03/01/21 Columbus McKinnon acquires Dorner Manufacturing for $485less than 12/08/20 Columbus McKinnon announces Intelli-Guide Auto-Dispatch System CMCO Columbus McKinnon $53.06 / +0.86 (+1.65%) 02/26/21 DA Davidson Columbus McKinnon upgraded to Buy from Neutral at DA Davidson 02/26/21 DA Davidson Columbus McKinnon upgraded to Buy from Neutral at DA Davidson 01/29/21 Barrington Columbus McKinnon price target raised to $56 from $43 at Barrington 01/21/21 Colliers Columbus McKinnon price target raised to $49 from $42 at Colliers CMCO Columbus McKinnon $53.06 / +0.86 (+1.65%) 01/28/21 Columbus McKinnon sees Q4 revenue $175M-$180M, consensus $165.77M 01/28/21 Columbus McKinnon reports Q3 EPS 27c, consensus 16c 10/29/20 Columbus McKinnon sees Q3 revenue $150M-$160M, consensus $162.88M 10/29/20 Columbus McKinnon reports Q2 EPS (17c), consensus 23c
Conference/Events	Quotient Technology participates in a conference call with Goldman Sachs » 10:42 03/02/21 03/02 10:42 03/02/21 10:42 QUOT Quotient Technology $14.10 / +0.08 (+0.57%) Goldman Sachs holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events QUOT Quotient Technology $14.10 / +0.08 (+0.57%) 02/11/21 Quotient Technology rises 28.7% 02/11/21 Quotient Technology rises 23.3% 02/11/21 Quotient Technology rises 16.5% 11/06/20 Quotient Technology falls -19.3% QUOT Quotient Technology $14.10 / +0.08 (+0.57%) 02/11/21 Craig-Hallum Quotient Technology price target raised to $25 from $14 at Craig-Hallum 03/27/20 BofA Quotient Technology upgraded to Buy from Neutral at BofA 03/27/20 BofA Quotient Technology upgraded to Buy from Underperform at BofA QUOT Quotient Technology $14.10 / +0.08 (+0.57%) 02/10/21 Quotient Technology reports Q4 EPS (28c), consensus(6c) 11/05/20 Quotient Technology sees Fy20 revenue $418M-$428M, consensus $438.88M 11/05/20 Quotient Technology sees Q4 adj. EBITDA $10M-$15M 11/05/20 Quotient Technology reports Q3 EPS (5c), consensus (5c) 00:00 Today Technology, Media & Telecom Virtual Conference
Syndicate	Advanced Merger Partners opens at $10.10, IPO priced at $10 » 10:40 03/02/21 03/02 10:40 03/02/21 10:40 AMPI Advanced Merger Partners $0.00 / + (+0.00%) Advanced Merger Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
On The Fly	Citi says buy Beyond Meat, has 'new-found enthusiasm' following partnerships » 10:40 03/02/21 03/02 10:40 03/02/21 10:40 BYND Beyond Meat $149.35 / +2.24 (+1.52%) , PEP PepsiCo $130.85 / +0.23 (+0.18%) , YUM Yum! Brands $104.06 / -0.49 (-0.47%) , MCD McDonald's $206.80 / -1.45 (-0.70%) Shares of Beyond Meat… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BYND PEP YUM MCD BYND Beyond Meat $149.35 / +2.24 (+1.52%) 02/25/21 Beyond Meat says currently in 'solid liquidity position' 02/25/21 Beyond Meat says proceeding with 'aggressive investment agenda' in 2021 02/25/21 Beyond Meat says seeing 'great growth' in household penetration 02/25/21 Beyond Meat says 'not prepared to elaborate' on new partnerships PEP PepsiCo $130.85 / +0.23 (+0.18%) 02/25/21 PepsiCo launches Neon Zebra, a new line of non-alcoholic cocktail mixers 02/17/21 PepsiCo chooses e.fundamentals to power its ecommerce growth in Europe 02/11/21 PepsiCo would 'not expect much in the way of M&A' in 2021 02/11/21 PepsiCo sees FY21 core operating margin declining YUM Yum! Brands $104.06 / -0.49 (-0.47%) 07:35 Today Yum! Brands to acquire consumer insights business from Kvantum 02/25/21 Beyond Meat says seeing 'great growth' in household penetration 02/25/21 Beyond Meat partners with Yum! Brands on plant-based protein menu items 02/10/21 Magellan Asset Management reports 5.62% passive stake in Yum! Brands MCD McDonald's $206.80 / -1.45 (-0.70%) 06:07 Today McDonald's CEO vows to crack down on sexual harassment in the workplace 02/25/21 Beyond Meat says seeing 'great growth' in household penetration 02/25/21 Beyond Meat signs three-year agreement to be McPlant supplier for McDonald's 01/28/21 McDonald's sees FY21 system wide sales growth of low double digits BYND PEP YUM MCD BYND Beyond Meat $149.35 / +2.24 (+1.52%) 09:56 Today Fly Intel: Top five analyst upgrades 07:13 Today Citi Citi upgrades Beyond Meat to Buy with 'new-found enthusiasm' for long-term story 07:07 Today Citi Beyond Meat upgraded to Buy from Neutral at Citi 03/01/21 DA Davidson Beyond Meat price target raised to $145 from $133 at DA Davidson PEP PepsiCo $130.85 / +0.23 (+0.18%) 07:13 Today Citi Citi upgrades Beyond Meat to Buy with 'new-found enthusiasm' for long-term story 02/03/21 Deutsche Bank PepsiCo price target raised to $148 from $143 at Deutsche Bank 01/27/21 Canaccord Beyond Meat price target raised to $170 from $125 at Canaccord 01/26/21 Wells Fargo JV doesn't change near-term trajectory for Beyond Meat, says Wells Fargo YUM Yum! Brands $104.06 / -0.49 (-0.47%) 07:13 Today Citi Citi upgrades Beyond Meat to Buy with 'new-found enthusiasm' for long-term story 02/22/21 Wells Fargo Wells Fargo strategist upgrades Consumer Services sector to Overweight 02/05/21 Deutsche Bank Yum! Brands price target raised to $113 from $107 at Deutsche Bank 01/19/21 Goldman Sachs Yum! Brands initiated with a Sell at Goldman Sachs MCD McDonald's $206.80 / -1.45 (-0.70%) 07:13 Today Citi Citi upgrades Beyond Meat to Buy with 'new-found enthusiasm' for long-term story 02/22/21 Wells Fargo Wells Fargo strategist upgrades Consumer Services sector to Overweight 02/01/21 Citi Citi opens 'Catalyst Watch' on McDonald's into chicken sandwich launch 01/21/21 UBS UBS sees 'golden' risk reward for McDonald's BYND PEP YUM MCD BYND Beyond Meat $149.35 / +2.24 (+1.52%) 02/25/21 Beyond Meat reports Q4 adjusted EPS (34c), consensus (13c) 02/25/21 Notable companies reporting after market close 11/09/20 Beyond Meat reports Q3 adj. EPS (28c), consensus 5c 11/09/20 Notable companies reporting after market close PEP PepsiCo $130.85 / +0.23 (+0.18%) 02/11/21 PepsiCo sees FY21 core constant currency EPS up high-single digits 02/11/21 PepsiCo reports Q4 core EPS $1.47, consensus $1.46 02/10/21 Notable companies reporting before tomorrow's open 02/10/21 Notable companies reporting before tomorrow's open YUM Yum! Brands $104.06 / -0.49 (-0.47%) 02/04/21 Yum! Brands reports Q4 ex-items EPS $1.15, consensus $1.01 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open 10/29/20 Yum! Brands reports Q3 EPS $1.01, consensus 80c MCD McDonald's $206.80 / -1.45 (-0.70%) 01/28/21 McDonald's reports Q4 non-GAAP EPS $1.70, consensus $1.78 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 11/09/20 McDonald's reports Q3 ex-items EPS $2.22, consensus $1.90 BYND PEP MCD BYND Beyond Meat $149.35 / +2.24 (+1.52%) 02/26/21 McDonald's clarifies to Bloomberg Beyond Meat's 'preferred supplier' status 02/04/21 Lawsuit challenging FDA approval of Impossible color additive, FSN reports 02/01/21 McDonald's begins introduction of McPlant Burger in test markets, Bloomberg says 11/09/20 Beyond Meat up 4% after confirming partnership with McDonald's for 'McPlant' PEP PepsiCo $130.85 / +0.23 (+0.18%) 01/15/21 Coca-Cola won't run ads during Super Bowl, Variety reports 09/14/20 PepsiCo to launch Driftwell sleep aid beverage, CNBC reports MCD McDonald's $206.80 / -1.45 (-0.70%) 02/28/21 McDonald's considering selling part of Dynamic Yield, Bloomberg reports 02/26/21 McDonald's clarifies to Bloomberg Beyond Meat's 'preferred supplier' status 02/09/21 Burger King testing loyalty program in five U.S. markets, CNBC reports 02/02/21 Judge rejects former McDonald's CEO's bid to dismiss lawsuit, Reuters reports BYND PEP YUM MCD BYND Beyond Meat $149.35 / +2.24 (+1.52%) 03/01/21 Fly Intel: After-Hours Movers 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Fly Intel: Wall Street's top stories at midday 02/26/21 Fly Intel: Pre-market Movers PEP PepsiCo $130.85 / +0.23 (+0.18%) 02/25/21 Fly Intel: What to watch in Beyond Meat earnings report 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday 02/09/21 Fly Intel: What to watch in Coca-Cola earnings report YUM Yum! Brands $104.06 / -0.49 (-0.47%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Fly Intel: Wall Street's top stories at midday 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 11/10/20 Beyond Meat plunges following surprise loss on 'full brunt of COVID' MCD McDonald's $206.80 / -1.45 (-0.70%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: What to watch in Beyond Meat earnings report 01/27/21 Fly Intel: What to watch in McDonald's earnings report 04/15/21 PepsiCo - PEP BYND PEP YUM MCD BYND Beyond Meat $149.35 / +2.24 (+1.52%) 09:40 Today Unusually active option classes on open March 2nd 08:45 Today Largest borrow rate increases among liquid names 01/25/21 Beyond Meat call volume above normal and directionally bullish 01/22/21 Beyond Meat call volume above normal and directionally bullish PEP PepsiCo $130.85 / +0.23 (+0.18%) 01/26/21 Unusually active option classes on open January 26th 01/20/21 Unusual call flow in option market yesterday 01/19/21 $1.2M upside call Seller in PepsiCo 09/30/20 Unusually active option classes on open September 30th YUM Yum! Brands $104.06 / -0.49 (-0.47%) 09/08/20 Yum! Brands put volume heavy and directionally bearish MCD McDonald's $206.80 / -1.45 (-0.70%) 09:40 Today Unusually active option classes on open March 2nd 09/09/20 Unusually active option classes on open September 9th 09/02/20 McDonald's call volume above normal and directionally bullish
Recommendations	Turning Point has 'many value-driving catalysts' in 2021, says Roth Capital » 10:37 03/02/21 03/02 10:37 03/02/21 10:37 TPTX Turning Point Therapeutics $119.25 / -1.32 (-1.09%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events TPTX Turning Point Therapeutics $119.25 / -1.32 (-1.09%) 01/29/21 Turning Point reports interim data from Phase 2 Trident-1 study of repotrectinib 01/11/21 Turning Point Therapeutics expects cash to fund operations into 2024 01/11/21 Turning Point Therapeutics announces 2021 milestone targets 01/11/21 Turning Point Therapeutics, Zai Lab expand collaboration to include TPX-0022 TPTX Turning Point Therapeutics $119.25 / -1.32 (-1.09%) 02/02/21 Canaccord Turning Point Therapeutics price target raised to $145 from $122 at Canaccord 01/29/21 Roth Capital Turning Point Therapeutics price target raised to $170 from $140 at Roth Capital 01/19/21 H.C. Wainwright Turning Point Therapeutics price target raised to $190 from $130 at H.C. Wainwright 01/12/21 Oppenheimer Turning Point Therapeutics price target raised to $150 from $130 at Oppenheimer TPTX Turning Point Therapeutics $119.25 / -1.32 (-1.09%) 03/01/21 Turning Point Therapeutics reports Q4 EPS ($1.02), consensus(92c) 27 Oct 19 May 03/16/21 31st Annual Healthcare Virtual Conference

Events

Earnings calls, analyst events, roadshows and more

DIN
Today at 12:00

Dine Brands - DIN Conference Calls
IPI
Today at 12:00

Intrepid Potash - IPI Conference Calls
NAV
Today at 12:00

Navistar International Corp. Firm Sponsored Meetings
PS
Today at 12:30

Pluralsight, Inc. Firm Sponsored Meetings
Today at 13:00

Fed Governor Speaks on US Economic Outlook Government Event

Virtual Evemt
PGR
Today at 13:00

Progressive - PGR Conference Calls
WORK
Today at 13:00

Slack Technologies, Inc. Firm Sponsored Meetings
PGR
Today at 13:00

Progressive Corporation Firm Sponsored Meetings

Virtual Meeting
SNOW
Today at 13:00

Software & Internet Industry Meetings
Today at 13:00

Consumer Goods Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $36.00-38.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Mizuho to hold virtual company meetings at conference

TODAY'S FREE FLY STORIES

Get Full Fly Access